Read More Pharma Industry News Merck to acquire coronavirus vaccine candidate developer Themis Bioscience Merck acquisition of Themis Bioscience : Merck has signed a deal to acquire Themis Bioscience, an Austrian vaccine… bypharmanewsdailyMay 27, 2020
